CurrentEndo
Get Weekly

Topic · page 34 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 1,321–1,360 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. J Bone Miner Res

    PPI-Induced Changes in Plasma Metabolite Levels Influence Total Hip Bone Mineral Density in a UK Cohort

    Cohort study

  2. Osteoporos Int

    Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging

    Cohort study

  3. Osteoporos Int

    Fracture liaison service model: project design and accreditation

    Research article

  4. Osteoporos Int

    A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

    Cohort study

  5. Osteoporos Int

    Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury

    Diagnostic or prognostic study

  6. J Clin Endocrinol Metab

    Antiresorptive Medication Use Is not Associated With Acute Cardiovascular Risk: An Observational Study

    Cohort study

  7. Osteoporos Int

    Lipopolysaccharide-binding protein and bone health: data from a population-based sample of men

    Cross-sectional study

  8. Osteoporos Int

    An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures

    Cohort study

  9. Osteoporos Int

    Discontinuation of denosumab in men with prostate cancer

    Cohort study

  10. J Clin Endocrinol Metab

    Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis—the MiDeTe study

    Cohort study

  11. Osteoporos Int

    Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis

    Cohort study

  12. Osteoporos Int

    The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies

    Meta-analysis

  13. Osteoporos Int

    Should vertebral fracture assessment be performed in Fracture Liaison Service patients with non-vertebral fracture?

    Cohort study

  14. Osteoporos Int

    Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review

    Meta-analysis

  15. Osteoporos Int

    Prevalence of low bone mineral density (T-score ≤ − 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis

    Meta-analysis

  16. Osteoporos Int

    Risk of major osteoporotic fractures among ultra-orthodox Jews

    Cohort study

  17. Osteoporos Int

    Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males

    Cohort study

  18. Osteoporos Int

    Exercise and the prevention of major osteoporotic fractures in adults: a systematic review and meta-analysis with special emphasis on intensity progression and study duration

    Meta-analysis

  19. Osteoporos Int

    Association of covert brain infarcts and white matter hyperintensities with risk of hip fracture in older adults: the Cardiovascular Health Study

    Cohort study

  20. Endocr Pract

    Parathyroid Cystic Adenoma: A Systematic Review and Meta-Analysis

    Meta-analysis

  21. Clin Endocrinol (Oxf)

    Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo‐controlled randomized trial

    Randomized controlled trial

  22. Osteoporos Int

    m2ABQ—a proposed refinement of the modified algorithm-based qualitative classification of osteoporotic vertebral fractures

    Guideline or statement

  23. Osteoporos Int

    Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy

    Cross-sectional study

  24. J Bone Miner Res

    Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT

    Research article

  25. J Clin Endocrinol Metab

    Hyperparathyroidism in a Large Cohort of Chinese Patients With Tumor-induced Osteomalacia

    Cohort study

  26. J Bone Miner Res

    The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension

    Randomized controlled trial

  27. Osteoporos Int

    Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA

    Cohort study

  28. J Clin Endocrinol Metab

    Genotype-phenotype Description of Vitamin D–dependent Rickets 1A: CYP27B1 p.(Ala129Thr) Variant Induces a Milder Disease

    Cohort study

  29. J Clin Endocrinol Metab

    Comparisons Between Different Anti-osteoporosis Medications on Postfracture Mortality: A Population-Based Study

    Cohort study

  30. Osteoporos Int

    High rate of abdominal aortic calcification in COPD patients and its relationship with musculoskeletal fragility

    Cross-sectional study

  31. Osteoporos Int

    Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women

    Randomized controlled trial

  32. Osteoporos Int

    Effectiveness of whole-body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials

    Meta-analysis

  33. Osteoporos Int

    The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis

    Guideline or statement

  34. J Bone Miner Res

    Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial

    Randomized controlled trial

  35. J Bone Miner Res

    Longitudinal Change in Bone Density, Geometry, and Estimated Bone Strength in Older Men and Women From The Gambia: Findings From the Gambian Bone and Muscle Aging Study (GamBAS)

    Cohort study

  36. J Clin Endocrinol Metab

    Sex Differences in Phosphate Homeostasis: Females Excrete More Phosphate and Calcium After an Oral Phosphate Challenge

    Cross-sectional study

  37. Osteoporos Int

    Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study

    Cross-sectional study

  38. Osteoporos Int

    Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study

    Cohort study

  39. Osteoporos Int

    Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05

    Randomized controlled trial

  40. Osteoporos Int

    Pharmacist interventions in osteoporosis management: a systematic review

    Meta-analysis

All 1,367 Briefs in ExploreShowing Briefs 1,321–1,360 of 1,367, newest first